The company (TITXF) recently completed a secondary round of financing by selling approx 9 million shares which was completed on Feb 20. This should carry them for about 12-14 months. The stock sold off from $1.55 to around $1.23 where its now trading. Robotics seems to be the next rage of the Street (ex. Google buying up robotic companies) The robotic surgical platform and software of TITXF corrects many of the problems of the da Vinci system manufactured by ISRG. Another robotic company TRXC who is also developing a robotic surgical platform has gone up 50% this week with a market cap of 400mil compared to TITXF 87mil . This offers a huge potential return once it gets out. My friend, a surgeon at Columbia tells me alot of surgeons are buying this stock as well as the reps of ISRG. Just sharing what I know. Thank you for your time .